SPIMACO was established in the year 1986 in the Kingdom of Saudi Arabia (as a Public Joint Stock Company). SPIMACO and its subsidiaries are engaged in medical and pharmaceutical production including manufacturing, producing, developing, marketing, selling and distributing pharmaceutical raw materials, medical and pharmaceutical solutions, production supplies, medical and pharmaceutical supplies and equipment in addition to producing medical consumables in addition to other investment in many companies.SPIMACO capital amounts to SAR 1.2 billion, of which ACDIMA owns 20.488%.